Skip to main content

Advertisement

Open Peer Review Reports for: Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
13 Sep 2011 Submitted Original manuscript
27 Jan 2012 Reviewed Reviewer Report - Rudolf P. W├╝thrich
8 Feb 2012 Reviewed Reviewer Report - Andreas Serra
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
4 Apr 2012 Editorially accepted
4 Apr 2012 Article published 10.1186/1471-2369-13-17

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement